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A reverse phase high performance liquid chromatographic (RP-HPLC) method was developed for identification and estimation of
18-𝛽-glycyrrhetinic acid (GA) in HepG2 cell line. The analysis was carried out using a JASCO HPLC system with a C-18 (3 𝜇m)
Supelco reversed phase column (150 x 4.7mm) using a mobile phase of 80% CH
3
OH and 20% of CH
3
CN: tetrahydrofuran: water
(10:80:10, v/v/v).Themethod was linear in the concentration range of 1.5–120 𝜇g /mL (n = 5). The LOD and LOQ were determined
based on standard deviation of the y-intercept and the slope of the calibration curve. The LOD and LOQ values were found to
be 11.46 𝜇g/mL and 34.72𝜇g/mL, respectively. The mean percentage recovery by standard addition experiments of GA is 92.4 %±
5.2%. The intracellular GA concentration value, obtained as mean of five different determinations, was 45.8 ± 7.45𝜇g/mL. We
have developed a HPLC-UV method for quantitative determination of GA inside cells, with advantages in the cost reduction and
economy of the analytical process.
1. Introduction
The use of natural substances as adjuvants in many drug
therapies is a new important trend in modern medicine,
due to a satisfactory clinical efficacy and a low degree of
toxicity [1–3]. Liquorice is a perennial plant with well-known
pharmacological properties that is largely employed in the
cosmetic and pharmacological fields, due to its several bio-
logical effects: antimicrobial, antiulcer, immunomodulatory,
anti-inflammatory, etc. [4–9].
One of the most active compounds of liquorice is
the triterpenoid glycyrrhizic acid (glycyrrhizin, GZ) and
the main product of its metabolism: the aglycone 18-𝛽-
glycyrrhetinic acid (GA) [5, 6]. GA exhibits corticosteroid
and mineral-corticoid activity due to the presence of the
𝛼,𝛽-unsaturated ketone group: in fact, GA is able to interact
withmineral-corticoid and glucocorticosteroid receptors and
exhibits anti-inflammatory properties [7]. Several studies
[10, 11] have reported that inappropriate use of licorice
can produce pseudoaldosteronism, by inactivating 11beta-
hydroxysteroid-dehydrogenase [11-𝛽HSD] and by binding to
mineralocorticoid receptors. 11-𝛽HSD catalyzes the oxida-
tion of the active mineralocorticoid, cortisol, to the inac-
tive cortisone and 11alpha-hydroxysteroiod-dehydrogenase is
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responsible for the reduction reaction. Thus, GA potenti-
ates the anti-inflammatory activity of cortisol by inhibiting
its intracellular inactivation. Moreover, GA is involved in
strengthen red blood cell membrane integrity against both
oxidative and proteolytic damage [12].
Moreover, in vitro studies showed that GA inhibits
the proliferation of different cancer cells [13–15], without
affecting normal cells [16–18]. This effect is probably due to
different mechanisms, such as downregulation of glutathione
(GSH) [17] and production of reactive oxygen species (ROS)
[18, 19]. However, all of the above reported actions are depen-
dent on the solubility of the compound in the hydrophilic
medium and, over all, on its ability to penetrate into cells
because its interactions with receptors and with enzymes
occur intracellularly. Given the lipid nature of GA, in in
vitro experiments, it has to be previously dissolved in DMSO
[20, 21]; this solvent has a polar domain and two nonpolar
groups, making GA soluble in both aqueous and organic
media [22]. Moreover, DMSO can induce water pores in
dipalmitoylphosphatidylcholine bilayers and this is a possi-
ble mechanism to increase penetration of active molecules
through lipid membranes [23].
Several analytical methods have been developed with
different techniques to evaluate the concentration of the var-
ious components of licorice in the preparations for cosmetic
and biomedical application. In several publications, analyti-
cal methods have been developed using High-Performance
Liquid Chromatography (HPLC) that is a very sensitive and
reproducible technique [24–29]. On these bases, the aim of
the present study was to develop a HPLC-UVmethod able to
carry out a quantitative determination of GA inside HepG2
cells. This human hepatocellular cell line was chosen because
these cells are able to metabolize GA [30]. To our knowledge,
in this paper a method for detection of GA inside cells is
reported, for the first time.
2. Materials and Methods
2.1. Chemicals and Reagents. 18-𝛽-glycyrrhetinic acid (GA)
was purchased from Acros Organics (VWR International
Srl, Milan, Italy). Cell culture medium and reagents, DMSO,
ethanol (EtOH), tetrahydrofuran (HPLC grade), and ace-
tonitrile (CH
3
CN, HPLC grade) were purchased from Sigma
Chemical (Milan, Italy). Methyl alcohol (CH
3
OH, HPLC
grade, Prolabo, France) and ultrapure water (obtained by a
P.Nix Power System apparatus, Human, Seoul, Korea) were
used for HPLC analyses.
2.2. HPLC Conditions. Standard solutions were analyzed
using a JASCOHPLC system (2 PU-980 pumps, UV-970UV/
VIS detector and AS-1555 autosampler). The analyses were
performed at a wavelength of 254 nm with a C-18 (3 𝜇m)
Supelco reversed phase column (150 x 4.7 mm) using amobile
phase of 80% CH
3
OH (A) and 20% of CH
3
CN: tetrahydro-
furan: water (10:80:10, v/v/v) (B) [modified from Chamoli
[31] (15min), 1.0mL/min flow, 50𝜇L injected volume]. Each
analysis was performed five times.
2.3. Cell Culture. HepG2, human liver carcinoma cells (Isti-
tuto Zooprofilattico, Brescia, Italy) were grown in a 5% CO
2
atmosphere at 37∘C in IMDM (Iscove’s Modified Dulbecco’s
Medium) with HEPES (10mM), glucose (4.5 g/L), NaHCO
3
(3.7 g/L), penicillin (100 units/mL), streptomycin (100 g/mL),
1% nonessential amino acids, and 10% fetal calf serum.
2.4. Cells Treatments. Stock solution of GA (200.0mmol/L)
was prepared immediately before use in DMSO, to obtain
a final concentration of 0.1% (v/v) DMSO, which does not
induce any alteration in cell vitality [32, 33]. The final
concentration of GA was 200 𝜇mol/L (94.14𝜇g/mL).
2.5. Determination of Intracellular Concentrations of GA.
HepG2 (5mL) were plated in 25 cm2 flasks at a density of
approximately 25,000 cells/cm2 and cultured to subconfluent
monolayers; GA (200𝜇mol/L) was then added and the cells
and incubated for 2 h at 37∘C. Cell monolayers without GA
were used as controls. After incubation, the cells were washed
in PBS solution and lysed by freezing (-80∘C). Cellular lysates
were resuspended in 1mL of EtOH and centrifuged (20,000
x g, 15min, 4∘C) and the supernatants were collected, evapo-
rated, and finally resuspended in 500𝜇L of EtOH. Samples
were analyzed as reported in HPLC conditions paragraph.
The concentration of GA in each sample was quantified using
the calibration curve performed with standard solutions
before each analysis. Each determination was repeated three
times and each experiment was performed 5 times (n=5)
2.6. Determination of Limit of Quantitation (LOQ) and Limit
of Detection (LOD). According to the ICH recommendations
[34], LOD and LOQ were determined based on standard
deviation of the y-intercept and the slope of the calibration
curve (n=5). Calibration curves were constructed from GA
standard solutions at 5 different concentrations within the
range of 1.5-120𝜇g/mL (1.5, 15, 30, 60 and 120 𝜇g/mL).
The following equations were used for calculating LOD
and LOQ:
LOD = (3, 3 × SD
slope
)
LOQ = (10 × SD
slope
)
(1)
2.7. Recovery Studies. The efficiency of GA recovery from cell
lysates was evaluated adding two different concentrations (20
and 40 𝜇g/mL) into control cellular lysates. Two replicates
of each concentration were prepared for each lysate. The
absolute recovery was evaluated as the ratio between the
experimentally observed concentration and the theoretical
concentration.
3. Results and Discussion
GA is a compound with several biological activities; for this
reason, it is widely used both in cosmetic and in medical
preparations. Since the biological effects of GA depend on
its intracellular concentration and not only its concentration
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Figure 1: Chromatographic profiles of HepG2 lysates. In intracellular sample, incubated for 2h with GA, a signal that corresponds to a
substance with the same elution time of GA was found (black); the described signal was not present in the untreated samples (pink). Inset:
Intracellular GA amount.
in culture medium, a simple HPLC-UV method for the
intracellular GA determination was developed and described
in this paper.
To be sure to be able to detect the exact intracellular
GA concentration, the method was first tested for linearity,
using calibrating standard solution mixtures of the GA
in concentration range 1.5–120 𝜇g/mL. Each determination
was repeated three times and each calibration curve was
performed 5 times (n=5). The obtained regression equation
was Y = 22017∗X – 21465 with R2 = 0.9946, confirming the
linearity of the response under the conditions used.The LOD
and LOQ were determined based on standard deviation of
the y-intercept and the slope of the calibration curve. The
LOD and LOQ values were found to be 11.46𝜇g/mL and
34.72𝜇g/mL, respectively.
We were then able to apply our analytical method to
identify and quantify the intracellular GA in cells treated with
a concentration of 200 𝜇mol/L of GA in cell culture medium
(94.14𝜇g/mL; 5mL). In these experimental conditions, no
cytotoxic effects were observed after two hours (data not
shown). In this preliminary phase of the study, this is very
important, since intracellular concentration of GA could
affect cellular vitality.
As shown in Figure 1 a signal corresponding to a sub-
stance with the same elution time of GA was found in cellular
lysates after incubation for 2 h with GA as shown in materials
and methods; the described signal was not present in the
untreated samples (controls).
The intracellular GA concentration value, obtained as
mean of five different experiments, was 45.8 ± 7.45𝜇g/mL.
Considering that the final volume of samples resuspended
in EtOH was 0.5mL (see materials and method) the true
amount of GA inside the cells was about 23𝜇g (Figure 1,
insert).
The GA percentage mean recovery by standard addition
experiments is 92.4% ± 5.2% (data not shown). These results
indicate the reliability of our analytical method.
4. Conclusions
Our HPLC-UV method for identification and quantification
of GA inside HepG2 cells, reliable in linearity and recovery,
could be used in different fields of pharmacology research
where themeasurement of intracellular concentrations of GA
is mandatory.
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